Organogenesis, Novartis amend deal

Amending a 1996 agreement, ORG granted Novartis (NVS; SWX:NOVN) the right to purchase an exclusive option to negotiate terms to license ORG's Vitrix living tissue composed of fibroblasts and collagen ...